- Home
- CBZ vs TMDX Comparison
CBZ vs TMDX Comparison
Compare CBZ & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBZ
- TMDX
- Stock Information
- Founded
- CBZ 1987
- TMDX 1998
- Country
- CBZ United States
- TMDX United States
- Employees
- CBZ N/A
- TMDX N/A
- Industry
- CBZ Business Services
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CBZ Consumer Discretionary
- TMDX Health Care
- Exchange
- CBZ Nasdaq
- TMDX Nasdaq
- Market Cap
- CBZ 4.0B
- TMDX 4.8B
- IPO Year
- CBZ N/A
- TMDX 2019
- Fundamental
- Price
- CBZ $72.19
- TMDX $113.93
- Analyst Decision
- CBZ Strong Buy
- TMDX Buy
- Analyst Count
- CBZ 1
- TMDX 10
- Target Price
- CBZ $86.00
- TMDX $127.33
- AVG Volume (30 Days)
- CBZ 533.0K
- TMDX 843.5K
- Earning Date
- CBZ 07-30-2025
- TMDX 07-30-2025
- Dividend Yield
- CBZ N/A
- TMDX N/A
- EPS Growth
- CBZ N/A
- TMDX N/A
- EPS
- CBZ 1.55
- TMDX 1.41
- Revenue
- CBZ $2,157,189,000.00
- TMDX $488,227,000.00
- Revenue This Year
- CBZ $58.65
- TMDX $34.07
- Revenue Next Year
- CBZ $5.74
- TMDX $20.76
- P/E Ratio
- CBZ $47.37
- TMDX $79.83
- Revenue Growth
- CBZ 32.27
- TMDX 64.43
- 52 Week Low
- CBZ $62.66
- TMDX $55.00
- 52 Week High
- CBZ $90.13
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- CBZ 51.40
- TMDX 34.85
- Support Level
- CBZ $70.04
- TMDX $122.48
- Resistance Level
- CBZ $74.04
- TMDX $127.97
- Average True Range (ATR)
- CBZ 1.84
- TMDX 5.69
- MACD
- CBZ 0.26
- TMDX -2.22
- Stochastic Oscillator
- CBZ 71.89
- TMDX 17.42
About CBZ CBIZ Inc.
CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.